Joseph Pressey

Clinical trials

• Pilot Study of Zoledronic Acid and Interleukin-2 for Refractory Pediatric Neuroblastoma

  Principal investigator · Terminated · Phase 1

  University of Alabama at Birmingham

  2011–2014
• A Study to Find the Highest Dose of Cedazuridine and Decitabine Combination With Filgrastim as a Treatment Option After Hematopoietic Stem Cell Transplant in Children With High-Risk Acute Myeloid Leukemia

  Site PI · Recruiting · Phase 1

  National Cancer Institute (NCI)

  2026–2027
• A Study to Find the Highest Dose of Imetelstat in Combination With Fludarabine and Cytarabine for Patients With AML, MDS or JMML That Has Come Back or Does Not Respond to Therapy

  Site PI · Recruiting · Phase 1

  Children's Oncology Group

  2025–2028
• Chemotherapy for the Treatment of Patients With Newly Diagnosed Very Low-Risk and Low Risk Fusion Negative Rhabdomyosarcoma

  Site PI · Recruiting · Phase 3

  Children's Oncology Group

  2022–2030